Target intelligence / Profile preview

Mitochondrial respiratory chain complex IV (Complex IV (also known as COX))

Target
Complex IV (also known as COX)
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial protein complex
01

Overview

Mitochondrial respiratory chain complex IV, also known as **cytochrome c oxidase** (COX), is the terminal enzyme of the mitochondrial electron transport chain. It catalyzes the transfer of electrons from reduced cytochrome c to molecular oxygen, reducing it to water. This process is coupled with pumping protons across the inner mitochondrial membrane, contributing to an electrochemical gradient used by ATP synthase for ATP production. Complex IV consists of multiple subunits—three core subunits encoded by mitochondrial DNA and additional nuclear DNA–encoded subunits—which together form a large metalloprotein assembly embedded in the inner mitochondrial membrane. The activity and assembly of this complex are tightly regulated; defects or inhibition can result in severe metabolic diseases such as Leigh syndrome and have been implicated in cancer, neurodegeneration, cardiovascular diseases, and other pathologies. Complex IV is also a central regulatory site for oxidative phosphorylation; its function can be modulated by steroids, thyroid hormones, phosphorylation events on its subunits, lipid environment changes, and small molecule inhibitors.

Other names
Cytochrome c oxidaseCOXElectron transport chain complex IVRespiratory chain complex IV
02

Mechanism of action

Inhibition of electron transfer and proton pumping by direct binding to the enzyme or interference with proton translocation pathways

03

Biological functions

Cellular respirationATP synthesis (via oxidative phosphorylation)Electron transport from cytochrome c to oxygenProton translocation across the inner mitochondrial membrane
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerMetabolic disorders (e.g., Leigh syndrome)
05

Safety considerations

Inhibition can lead to impaired cellular energy production and increased risk of lactic acidosis, neurodegeneration, or organ dysfunction in susceptible individuals
06

Interacting drugs

Steroids (e.g., glyco-diosgenin, cholesteryl hemisuccinate)

1 more in the full profile.

Beyond the preview

Go deeper on Mitochondrial respiratory chain complex IV (Complex IV (also known as COX)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial respiratory chain complex IV (Complex IV (also known as COX)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call